Crestline Management’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
2024
Q4
$2.59M Buy
2024
Q3
$624K Buy
2020
Q3
Sell
2020
Q2
$1.25M Buy